Diabetes mellitus and COVID-19: current state of knowledge

Introduction: Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate metabolism. Long-term high blood glucose levels can lead to a variety of serious complications and organ failure. Diabetic patients are particularly at risk of the severe course of COVID-1...

Full description

Bibliographic Details
Main Authors: Inga Wasilewska, Jakub Rezmer, Łukasz Świątek
Format: Article
Language:English
Published: Kazimierz Wielki University 2022-08-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/39559
_version_ 1828109789231579136
author Inga Wasilewska
Jakub Rezmer
Łukasz Świątek
author_facet Inga Wasilewska
Jakub Rezmer
Łukasz Świątek
author_sort Inga Wasilewska
collection DOAJ
description Introduction: Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate metabolism. Long-term high blood glucose levels can lead to a variety of serious complications and organ failure. Diabetic patients are particularly at risk of the severe course of COVID-19. Objective: The study aimed to investigate the relationship between diabetes and COVID-19. The literature available in the PubMed database was used to carry out a systematic review of the literature. The meta-analyzes from 2021 and 2022 were used for the analysis, with the inclusion of the phrases "DIABETES" and "COVID-19" in the title. A brief description of the state of knowledge: Diabetes does not increase the incidence of COVID-19, but the risk of severe disease is higher in patients with diabetes compared to the non-diabetic population. This is especially true of patients with uncontrolled glycaemia. SARS-CoV-2 disrupts the carbohydrate metabolism, can damage pancreatic beta cells and, in this mechanism, induce diabetes or cause the progression of pre-existing diabetes. There is an increased incidence of COVID-19 complications, including acute respiratory distress syndrome and death in patients with diabetes. Conclusions: Diabetic patients are at a higher risk of the severe course and rapid progression of COVID-19. Important in COVID-19 therapy is glycemic control and monitoring the percentage of glycosylated hemoglobin, CRP and D-dimers. The modification of the current treatment may be necessary. In patients who have undergone COVID-19, attention should be paid to the possibility of induction of diabetes or dysregulation of carbohydrate metabolism in patients suffering from diabetes previously.
first_indexed 2024-04-11T11:09:46Z
format Article
id doaj.art-86b209d35cef42308fc35baf07b75e43
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-04-11T11:09:46Z
publishDate 2022-08-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-86b209d35cef42308fc35baf07b75e432022-12-22T04:27:57ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062022-08-0112810.12775/JEHS.2022.12.08.101Diabetes mellitus and COVID-19: current state of knowledgeInga Wasilewska0Jakub Rezmer1Łukasz Świątek2Uniwersytet Medyczny w LublinieUniwersytet Medyczny w LublinieUniwersytet Medyczny w Lublinie Introduction: Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate metabolism. Long-term high blood glucose levels can lead to a variety of serious complications and organ failure. Diabetic patients are particularly at risk of the severe course of COVID-19. Objective: The study aimed to investigate the relationship between diabetes and COVID-19. The literature available in the PubMed database was used to carry out a systematic review of the literature. The meta-analyzes from 2021 and 2022 were used for the analysis, with the inclusion of the phrases "DIABETES" and "COVID-19" in the title. A brief description of the state of knowledge: Diabetes does not increase the incidence of COVID-19, but the risk of severe disease is higher in patients with diabetes compared to the non-diabetic population. This is especially true of patients with uncontrolled glycaemia. SARS-CoV-2 disrupts the carbohydrate metabolism, can damage pancreatic beta cells and, in this mechanism, induce diabetes or cause the progression of pre-existing diabetes. There is an increased incidence of COVID-19 complications, including acute respiratory distress syndrome and death in patients with diabetes. Conclusions: Diabetic patients are at a higher risk of the severe course and rapid progression of COVID-19. Important in COVID-19 therapy is glycemic control and monitoring the percentage of glycosylated hemoglobin, CRP and D-dimers. The modification of the current treatment may be necessary. In patients who have undergone COVID-19, attention should be paid to the possibility of induction of diabetes or dysregulation of carbohydrate metabolism in patients suffering from diabetes previously. https://apcz.umk.pl/JEHS/article/view/39559covid-19diabetesSARS-CoV-2
spellingShingle Inga Wasilewska
Jakub Rezmer
Łukasz Świątek
Diabetes mellitus and COVID-19: current state of knowledge
Journal of Education, Health and Sport
covid-19
diabetes
SARS-CoV-2
title Diabetes mellitus and COVID-19: current state of knowledge
title_full Diabetes mellitus and COVID-19: current state of knowledge
title_fullStr Diabetes mellitus and COVID-19: current state of knowledge
title_full_unstemmed Diabetes mellitus and COVID-19: current state of knowledge
title_short Diabetes mellitus and COVID-19: current state of knowledge
title_sort diabetes mellitus and covid 19 current state of knowledge
topic covid-19
diabetes
SARS-CoV-2
url https://apcz.umk.pl/JEHS/article/view/39559
work_keys_str_mv AT ingawasilewska diabetesmellitusandcovid19currentstateofknowledge
AT jakubrezmer diabetesmellitusandcovid19currentstateofknowledge
AT łukaszswiatek diabetesmellitusandcovid19currentstateofknowledge